glp 1 compound semaglutide Despite FDA ruling, compounded GLP-1s are still giving Novo and Lilly headaches on the market Compounded GLP-1 - Semaglutide &

Prescribers must document a specific, patient-level clinical rationale on every prescription

If you have purchased or used a suspected counterfeit product, stop using it immediately

Dan Med J

[11] [12] Currently available GLP-1 receptor agonists in the United States include semaglutide (Ozempic, Wegovy, Rybelsus), dulaglutide (Trulicity), liraglutide (Victoza, Saxenda), exenatide (Byetta, Bydureon BCise), and tirzepatide (Mounjaro, Zepbound)though tirzepatide is technically a dual GLP-1/GIP receptor agonist

There are, however, multiple instances of federal statute requiring a uniform pharmacy program benefit across all TRICARE categories -- instances which appear to run counter to the recent GLP-1 ruling

Even then, it maybe denied